Crossmark

The incremental value of aspartate aminotransferase/alanine aminotransferase ratio combined with CURB-65 in predicting treatment outcomes in hospitalized adult community-acquired pneumonia patients with type 2 diabetes mellitus

Crossref DOI link: https://doi.org/10.1186/s12890-025-03488-1

Published Online: 2025-01-17

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhou, Huamei

Zhu, Xuelei

Zhang, Yi

Xu, Wenjuan

Li, Shiqun
License Information

Text and Data Mining valid from 2025-01-17

Version of Record valid from 2025-01-17
More Information

Article History

Received: 23 February 2024

Accepted: 7 January 2025

First Online: 17 January 2025

Declarations

:

: Ethics approval for this study was obtained from the Ethics Committee of The People’s Hospital of Nanchuan, Chongqing (YXYJ-2021–016-01). As data were retrieved from existing medical records, the requirement for informed written consent from individual participants was waived.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below